Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Acquisition of BioSpin Clears Antitrust Period; Shareholders' Meeting Scheduled

NEW YORK (GenomeWeb News) – Bruker BioSciences said today that the Hart-Scott-Rodino waiting period for its proposed acquisition of affiliate Bruker BioSpin has expired.
 
Bruker BioSciences announced in early December that it had launched a $914 million takeover of Bruker BioSpin, which is 100 percent owned by members of the Laukien family, who also own 52 percent of publicly traded Bruker BioSciences.
 
Bruker also said today that it has scheduled a special meeting of its stockholders on Feb. 25 to vote on the proposed acquisition. Shareholders of record as of the close of business on Jan. 11 are eligible to vote on the transaction.
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.